Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (20 quarters reported)
$301M in Q4 2021 → $548M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| SE Space Exploration Techn Corp | 25.4% | Trimmed 34% | 923,218 | $139M |
| Aktis Oncology Inc | 11.9% | Added 8.9% | 3,343,827 | $65.1M |
| LB Latigo Biotherapeutics Inc | 11.0% | New | 3,596,780 | $60.1M |
| Larimar Therapeutics Inc | 5.8% | Added 8.3% | 9,923,904 | $31.7M |
| ET Electra Therapeutics Inc | 5.4% | New | 2,611,143 | $29.4M |
| NC Nuveen Churchill Direct Lend | 4.4% | Unchanged | 2,143,626 | $24.1M |
| Cullinan Therapeutics Inc | 3.9% | Trimmed 9.1% | 1,399,899 | $21.5M |
| Blue Owl Capital Corporation | 3.9% | Unchanged | 2,045,070 | $21.5M |
| Obsidian Therapeutics Inc | 3.7% | New | 1,482,767 | $20.4M |
| Sagimet Biosciences Inc | 2.0% | Trimmed 11% | 1,125,544 | $11.1M |
| Dell Technologies Inc | 1.9% | Trimmed 41% | 19,342 | $10.4M |
| Holley Inc | 1.9% | Unchanged | 4,376,888 | $10.3M |
| Conduent Inc | 1.4% | Unchanged | 5,036,595 | $7.86M |
| DF Deep Fission Inc | 1.2% | Unchanged | 1,333,333 | $6.84M |
| Aquestive Therapeutics Inc | 1.2% | Added 47% | 1,390,632 | $6.44M |
| Immix Biopharma Inc | 1.1% | Added 38% | 602,047 | $6.26M |
| Maplight Therapeutics Inc | 1.0% | Trimmed 24% | 556,371 | $5.67M |
| Veradermics Inc | 1.0% | New | 45,000 | $5.46M |
| Imagenebio Inc | 0.9% | Added 24% | 1,135,081 | $5.2M |
| Opus Genetics Inc | 0.9% | New | 969,605 | $4.69M |
| Corvus Pharmaceuticals Inc | 0.8% | Trimmed 41% | 358,600 | $4.13M |
| Rezolute Inc | 0.7% | New | 935,000 | $3.87M |
| Artiva Biotherapeutics Inc | 0.7% | Trimmed 39% | 529,542 | $3.77M |
| Cybin Inc | 0.6% | Added 381% | 288,282 | $3.54M |
| AL Achieve Life Science Inc | 0.6% | New | 412,654 | $3.34M |
| Procore Technologies Inc | 0.6% | New | 64,030 | $3.31M |
| Compass Therapeutics Inc | 0.6% | Trimmed 13% | 3,154,076 | $3.28M |
| PT Palvella Therapeutics Inc Ne | 0.6% | Trimmed 37% | 23,003 | $3.17M |
| Zura Bio Ltd | 0.6% | New | 735,000 | $3.06M |
| Lenz Therapeutics Inc | 0.5% | Added 3.3% | 781,722 | $3M |
| SP Starwood Ppty Tr Inc | 0.5% | Unchanged | 196,355 | $2.65M |
| PO Pyxis Oncology Inc | 0.4% | New | 1,000,000 | $2.33M |
| VT Viridian Therapeutics Inc | 0.4% | Trimmed 62% | 100,000 | $2.06M |
| Netskope Inc | 0.3% | New | 97,148 | $1.69M |
| Servicetitan Inc | 0.3% | New | 25,360 | $1.67M |
| First Advantage Corp | 0.3% | New | 88,665 | $1.58M |
| Eledon Pharmaceuticals Inc | 0.3% | Unchanged | 566,509 | $1.43M |
| WI Ww Intl Inc | 0.2% | Trimmed 16% | 71,277 | $1.1M |
| Adc Therapeutics Sa | 0.2% | Unchanged | 733,568 | $895K |
| Compass Pathways PLC Call | 0.2% | Trimmed 52% | 800,000 | $888K |
| Stablecoinx Inc | 0.2% | Trimmed 33% | 167,795 | $839K |
| Marker Therapeutics Inc | 0.1% | Unchanged | 554,250 | $593K |
| FH Fold Hldgs Inc | 0.1% | Unchanged | 856,632 | $454K |
| ND Niocorp Devs Ltd | 0.0% | Unchanged | 268,280 | $201K |
| Sagimet Biosciences Inc Call | 0.0% | New | 365,400 | $201K |
| Viking Therapeutics Inc Call | 0.0% | New | 300,000 | $181K |
| Piper Sandler Companies | 0.0% | Unchanged | 2,428 | $160K |
| Caris Life Sciences Inc | 0.0% | Unchanged | 4,711 | $144K |
| Rezolve Ai PLC | 0.0% | Unchanged | 235,121 | $129K |
| ET Energy Transfer L P | 0.0% | Unchanged | 5,326 | $105K |
| Engene Therapeutics Inc | 0.0% | Unchanged | 511,177 | $102K |
| Eledon Pharmaceuticals Inc Call | 0.0% | Unchanged | 200,000 | $100K |
| VG Vodafone Group PLC | 0.0% | Unchanged | 5,371 | $86.8K |
| Compass Therapeutics Inc Call | 0.0% | Added 104% | 619,700 | $48.8K |
| Brand Engagement Network Inc | 0.0% | Trimmed 49% | 746,953 | $37.3K |
| AM Alpha Modus Hldgs Inc | 0.0% | Unchanged | 1,854,665 | $37.1K |
| TR Tactical Res Corp | 0.0% | New | 11,250 | $29.9K |
| Monte Rosa Therapeutics Inc | 0.0% | New | 2,392 | $28.5K |
| Dave Inc | 0.0% | Unchanged | 28,750 | $28.2K |
| Roadzen Inc | 0.0% | Unchanged | 225,000 | $22.5K |
Showing top 60 of 79 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed November 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SE Space Exploration Techn Corp | Trimmed | −475,597 | −$71.7M | 25.4% |
| LB Latigo Biotherapeutics Inc | New | +3,596,780 | +$60.1M | 11.0% |
| ET Electra Therapeutics Inc | New | +2,611,143 | +$29.4M | 5.4% |
| CO Capital One Finl Corp | Exited | −119,757 | −$24M | — |
| Obsidian Therapeutics Inc | New | +1,482,767 | +$20.4M | 3.7% |
| Eyepoint Inc | Exited | −762,594 | −$10.9M | — |
| Dell Technologies Inc | Trimmed | −13,619 | −$7.33M | 1.9% |
| Rhythm Pharmaceuticals Inc | Exited | −61,455 | −$6.82M | — |
| Compass Pathways PLC | Exited | −450,000 | −$6.37M | — |
| UP Ultragenyx Pharmaceutical In | Exited | −182,638 | −$6.1M | — |
Showing the 10 largest of 55 changes.
quarter ended June 30, 2026 · filed August 11, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SE Space Exploration Techn Corp | New | +1,398,815 | +$239M | 36.0% |
| Engene Holdings Inc | Exited | −4,416,353 | −$30.1M | — |
| CO Capital One Finl Corp | New | +119,757 | +$24M | 3.6% |
| DF Deep Fission Inc | New | +1,333,333 | +$14.7M | 2.2% |
| Maplight Therapeutics Inc | Trimmed | −276,000 | −$9.89M | 3.9% |
| Artiva Biotherapeutics Inc | New | +874,542 | +$8.48M | 1.3% |
| Dell Technologies Inc | Added | +19,062 | +$8.22M | 2.1% |
| Sagimet Biosciences Inc | Added | +926,667 | +$7.16M | 1.5% |
| Cullinan Therapeutics Inc | Trimmed | −370,000 | −$6.74M | 4.2% |
| Compass Pathways PLC | New | +450,000 | +$6.37M | 1.0% |
Showing the 10 largest of 69 changes.
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Aktis Oncology Inc | New | +3,161,348 | +$56.6M | 15.2% |
| Maplight Therapeutics Inc | Added | +678,871 | +$13.8M | 5.5% |
| Repare Therapeutics Inc | Exited | −3,443,659 | −$8.95M | — |
| Corvus Pharmaceuticals Inc | New | +545,000 | +$7.97M | 2.1% |
| Engene Holdings Inc | Added | +1,055,416 | +$7.19M | 8.1% |
| Procore Technologies Inc | Exited | −94,264 | −$6.86M | — |
| Eyepoint Inc | Added | +520,000 | +$6.7M | 3.2% |
| Dell Technologies Inc | Trimmed | −39,949 | −$6.56M | 0.6% |
| Cullinan Therapeutics Inc | Trimmed | −441,208 | −$6.27M | 7.3% |
| Context Therapeutics Inc | Trimmed | −2,343,891 | −$6.14M | 3.6% |
Showing the 10 largest of 73 changes.
quarter ended December 31, 2025 · filed February 20, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Evercommerce Inc | Exited | −1,641,929 | −$18.3M | — |
| Roivant Sciences Ltd | Trimmed | −725,000 | −$15.7M | 1.8% |
| NC Nuveen Churchill Direct Lend | Trimmed | −947,927 | −$12.6M | 8.8% |
| Procore Technologies Inc | New | +94,264 | +$6.86M | 2.1% |
| Disc Medicine Inc | Exited | −102,260 | −$6.76M | — |
| PT Palvella Therapeutics Inc Ne | Trimmed | −55,000 | −$5.76M | 1.3% |
| Maplight Therapeutics Inc | New | +327,058 | +$5.74M | 1.8% |
| Immix Biopharma Inc | New | +986,240 | +$5.16M | 1.6% |
| Korro Bio Inc | Exited | −105,000 | −$5.03M | — |
| UP Ultragenyx Pharmaceutical In | Trimmed | −209,800 | −$4.83M | 1.5% |
Showing the 10 largest of 56 changes.
quarter ended September 30, 2025 · filed November 12, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tourmaline Bio Inc | Exited | −997,107 | −$15.9M | — |
| Roivant Sciences Ltd | New | +988,249 | +$15M | 4.6% |
| NC Nuveen Churchill Direct Lend | Trimmed | −948,000 | −$13.1M | 13.2% |
| Mineralys Therapeutics Inc | Trimmed | −235,000 | −$8.91M | 1.2% |
| Tango Therapeutics Inc | Trimmed | −695,000 | −$5.84M | 0.3% |
| Ikena Oncology Inc | Exited | −4,091,118 | −$5.48M | — |
| Tempus Ai Inc | Exited | −80,167 | −$5.09M | — |
| UP Ultragenyx Pharmaceutical In | Added | +167,200 | +$5.03M | 3.9% |
| Dell Technologies Inc | Added | +31,486 | +$4.46M | 2.3% |
| Imagenebio Inc | New | +540,924 | +$4.41M | 1.4% |
Showing the 10 largest of 37 changes.
quarter ended June 30, 2025 · filed August 11, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| PT Proshares Tr | Exited | −175,000 | −$10M | — |
| Tango Therapeutics Inc | Trimmed | −1,307,236 | −$6.69M | 1.3% |
| Tempus Ai Inc | New | +80,167 | +$5.09M | 1.6% |
| UP Ultragenyx Pharmaceutical In | Added | +102,000 | +$3.71M | 3.0% |
| E2open Parent Holdings Inc | Exited | −1,650,943 | −$3.3M | — |
| Conduent Inc | Trimmed | −1,240,602 | −$3.28M | 3.8% |
| Keros Therapeutics Inc | Exited | −266,033 | −$2.71M | — |
| SP Starwood Ppty Tr Inc | New | +131,461 | +$2.64M | 0.9% |
| Dell Technologies Inc | New | +20,848 | +$2.56M | 0.8% |
| Compass Pathways PLC | Trimmed | −905,914 | −$2.54M | 0.2% |
Showing the 10 largest of 47 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Klaviyo Inc | Exited | −1,078,770 | −$44.5M | — |
| PT Proshares Tr | New | +175,000 | +$10M | 3.2% |
| Acelyrin Inc | Exited | −2,783,946 | −$8.74M | — |
| Civeo Corp | New | +348,226 | +$8.01M | 2.6% |
| Holley Inc | Added | +2,327,746 | +$5.98M | 4.4% |
| Mineralys Therapeutics Inc | New | +206,296 | +$3.28M | 1.1% |
| Palvella Therapeutics Inc | Trimmed | −109,803 | −$3.07M | 1.3% |
| Compass Pathways PLC | Added | +974,590 | +$2.79M | 1.0% |
| Nextnav Inc | New | +198,760 | +$2.42M | 0.8% |
| Mereo Biopharma Group PLC | Exited | −672,809 | −$2.35M | — |
Showing the 10 largest of 49 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| PT Proshares Tr | Exited | −325,000 | −$23.6M | — |
| Tourmaline Bio Inc | Trimmed | −451,080 | −$9.15M | 5.0% |
| Conduent Inc | Added | +2,262,437 | +$9.14M | 5.2% |
| Eledon Pharmaceuticals Inc | New | +1,959,912 | +$8.07M | 1.9% |
| Lanzatech Global Inc | Exited | −2,926,514 | −$5.59M | — |
| Tango Therapeutics Inc | New | +1,732,152 | +$5.35M | 1.2% |
| CI Ccc Intelligent Solutions Hl | Exited | −457,104 | −$5.05M | — |
| Eyepoint Pharmaceuticals Inc | New | +667,594 | +$4.97M | 1.1% |
| Klaviyo Inc | Trimmed | −119,500 | −$4.93M | 10.3% |
| Starwood Property Trust | Exited | −226,456 | −$4.62M | — |
Showing the 10 largest of 106 changes.
Loading...